Phase 2 FAP Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
Pancreatic CancerFAPIPositron Emission Tomography+5 more
Turku University Hospital100 enrolled1 locationNCT07098598
Recruiting
Phase 2
The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
CancerPleural MesotheliomaPleural Diseases+2 more
Aalborg University Hospital70 enrolled1 locationNCT06790082
Recruiting
Phase 2Phase 3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Gastric CancerPancreatic Ductal AdenocarcinomaOncology+3 more
KU Leuven109 enrolled3 locationsNCT06782412
Recruiting
Phase 2
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
Pulmonary FibrosisIdiopathic Pulmonary FibrosisFAP+1 more
Erasme University Hospital70 enrolled1 locationNCT06189820